PTJ
CELG

Paul Tudor Jones’s Celgene Corp CELG Stock Holding History

Paul Tudor Jones’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-443,600
Closed -$44M – 1506
2019
Q3 		$44M Sell
443,600
-48,400
-10% -$4.6M 1.51% 6
2019
Q2 		$45.5M Sell
492,000
-660,100
-57% -$62.7M 1.3% 9
2019
Q1 		$109M Buy
+1,152,100
New +$101M 4.49% 3

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $341K AUM 32.64% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Paul Tudor Jones's CELG Position: Q4 2019 in Review

Paul Tudor Jones sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,292,572 shares — an estimated $128M sold.

Paul Tudor Jones first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $128M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Paul Tudor Jones reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Paul Tudor Jones sold 1,292,572 Celgene Corp shares in Q4 2019, an estimated $128M.
  • Paul Tudor Jones first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
  • Paul Tudor Jones's Celgene Corp position peaked at $128M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Tudor Investment Corp's 13F filing for Q4 2019, filed 14 Feb 2020.